Literature DB >> 11595992

Preventing vascular catheter-related infections: current controversies.

B M Farr1.   

Abstract

Prevention of vascular catheter-related infection remains an important priority. This review focuses on salient controversies regarding optimal preventive methods. Intensity of surveillance for nosocomial infections was the single most important predictor of prevention in the Study of the Efficacy of Nosocomial Infection Control (SENIC). Used suboptimally by most hospitals in the SENIC study, surveillance is probably conducted even less today. There has been one randomized trial of the optimal method of aseptic insertion for central venous catheters and none comparing the 2 most frequently used sites. Scheduled replacement did not prevent infection in multiple randomized trials but, according to a recent survey, was still being used frequently. Chlorhexidine preparation of skin before and during catheterization has significantly reduced colonization of catheters in multiple randomized trials and should be used. Impregnation of catheter and/or hub surfaces with antiseptics raises less concern about fostering the development of antibiotic resistance than does the use of antibiotics for this purpose.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11595992     DOI: 10.1086/323402

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  3 in total

1.  Patterns of nitrogen and carbon stable isotope ratios in macrofungi, plants and soils in two old-growth conifer forests.

Authors:  Steven A Trudell; Paul T Rygiewicz; Robert L Edmonds
Journal:  New Phytol       Date:  2004-11       Impact factor: 10.151

2.  A Cautionary Tale on the Central Venous Catheter: Medical Note for Oral Physicians.

Authors:  Ramasamy Chidambaram
Journal:  Malays J Med Sci       Date:  2015-09

3.  Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization.

Authors:  Anjali Shah; James Mond; Scott Walsh
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.